UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021332
Receipt number R000022961
Scientific Title The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function
Date of disclosure of the study information 2016/03/04
Last modified on 2021/03/08 09:45:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function

Acronym

The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function

Scientific Title

The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function

Scientific Title:Acronym

The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function

Region

Japan


Condition

Condition

fatigue

Classification by specialty

Medicine in general Hematology and clinical oncology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The evaluation of the effect of jyuzentaihoto on NK cell function

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

NK cell function

Key secondary outcomes

Numerical Rating Scale and questionnaires of general fatigue


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

jyuzentaihoto

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

No subjective symptom, drinking three times or less a week, and normal liver and renal function that has been confirmed in a medical examination within one year.

Key exclusion criteria

Any of the following: currently receiving a drug therapy, currently having chronic diseases such as heart, lung, kidney, gastrointestinal, and inflammatory diseases, suffering from invasive cancer within five years, suffering from non-invasive cancer within a year, and a history of smoking within one year.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Keiko
Middle name
Last name Keiko Ogawa

Organization

Kanazawa University Hospital

Division name

Department of Kampo Medicine

Zip code

920-8641

Address

13-1 ,Takara-machi, Kanazawa

TEL

076-265-2918

Email

okeiko@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name Keiko
Middle name
Last name Ogawa

Organization

Kanazawa University Hospital

Division name

Department of Kampo Medicine

Zip code

920-8641

Address

Kanazawa

TEL

09060322222

Homepage URL


Email

okeiko@med.kanazawa-u.ac.jp


Sponsor or person

Institute

Kanazawa University

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanazawa University Hospital

Address

13-1, Takara-machi,Kanazawa

Tel

09060322222

Email

ikkandoo@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学附属病院


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 11 Month 27 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 10 Day

Last follow-up date

2015 Year 11 Month 30 Day

Date of closure to data entry

2016 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 09 Month 30 Day

Date analysis concluded

2016 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 03 Month 04 Day

Last modified on

2021 Year 03 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022961


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name